Pancreolan Forte (Pancreatin)

Pancreatin, the active ingredient in Pancreolan Forte, is a digestive enzyme presented as a pancreatic enzyme replacement therapy for oral use. It aids digestion in patients with pancreatic exocrine insufficiency, such as those with cystic fibrosis, chronic pancreatitis, or after pancreatic surgery. GNH USA supplies Pancreolan Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Pancreolan Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Pancreolan Forte is a pancreatic enzyme replacement that acts on the digestive system to improve nutrient breakdown.

- Cystic fibrosis: improves absorption of fats, proteins and carbohydrates. - Chronic pancreatitis: reduces steatorrhea and abdominal discomfort. - Post‑pancreatic surgery: supports digestion when endogenous enzyme production is reduced. - Pancreatic cancer-associated exocrine insufficiency: aids in maintaining nutritional status. - Zollinger‑Ellison syndrome treated with acid‑suppression therapy: enhances digestion when acid‑lowering drugs diminish enzyme activity.

Pancreolan Forte may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Abdominal cramping - Flatulence - Nausea - Diarrhoea - Constipation - Mild skin rash

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Angio‑angulation - Persistent vomiting - Pancreatitis-like abdominal pain - Significant weight loss despite therapy - Respiratory distress caused by inhaled enzyme particles

Pancreolan Forte should be used with caution in specific clinical situations.

- Assess the risk of allergy to porcine derived materials : review all available medical history for potential sensitivities. - Monitor for gastro‑     ");